Google_______________

Survey Confirms Outbreak of Recently Acquired Hepatitis C among Gay Men in London

By Liz Highleyman

At several HIV and hepatitis conferences over the past few years, researchers have been reporting on outbreaks of acute, apparently sexually transmitted hepatitis C virus (HCV) infection among men who have sex with men (MSM) in various cities in the U.K. and Europe. Most reported cases have been in HIV positive men, but a recent study showed that acute HCV infection also occurs in HIV negative men.

Researchers with the U.K. Health Protection Agency presented further data on the outbreak in London at the recent British HIV Association annual meeting in April (also published in the May 2007 supplemental issue of HIV Medicine).

The objective of their study was to ascertain the burden and geographic extent of
diagnosed recently acquired HCV infection among in MSM in London in order to inform public health interventions.

The investigators used a questionnaire-based survey of HIV and genitourinary medicine (GUM) clinics to assess recently acquired HCV in MSM attendees between 2002 and June 2006. Diagnosed recently acquired HCV was defined as a positive PCR HCV RNA or antibody test in patients who had a negative HCV test in the previous 3 years.

Results

13 HIV centers in London responded to the survey, covering 85% of MSM who received HIV care in the city.

By 2006, all clinics reported routine screening for HCV, but only 5 reported routine screening over the entire period.

A total of 352 cases of diagnosed recently acquired HCV were reported (arising from 39,306 person years of observation), for an overall incidence rate of 9.0 cases per 1000 person years.

The range across different clinics was 0 to 15.4 cases per 1000 person years.

The estimated annual increase in incidence of diagnosed recently acquired HCV was 20%.

There was no evidence that this was affected by routine HCV screening.

Little information was available for HIV negative MSM, since most GUM clinics did not routinely screen all MSM for HCV.

Conclusion

In conclusion, the researchers wrote, "This study provides some evidence of increasing incidence in [diagnosed recently acquired HCV] in HIV positive MSM attending HIV centres across London since 2002. Yet there still are many gaps in our understanding, especially related to the burden of disease in HIV [negative] MSM. Close collaboration between clinicians and public health specialists will be key to inform public health interventions and potentially required surveillance."

05/15/07

Reference
M Ruf, I Giraudon, H Maguire, and others. Evidence of increase in recently acquired hepatitis C in HIV-positive men who have sex with men across London, 2002-2006. HIV Medicine 8(s1): 1-8. May 2007.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FDA-approved
Monotherapies for HCV
Intron A
Roferon

Infergen

Pegasys

PEG-Intron

FDA-approved
Combination
Therapies
for HCV
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
Index of All
Hepatitis C Articles
by Topic ( A to Z)